Skip to main content
. 2015 Sep 25;9:5345–5354. doi: 10.2147/DDDT.S89214

Table 2.

Populations of patients evaluated for safety and efficacy of inVag® treatment

Total number of patients Patients using inVag Patients using placebo
Patients (randomized) 160 (100%) 86 (100%) 74 (100%)
Safety evaluation (S) 141 (88%) 76 (88%) 65 (88%)
Efficacy evaluation (E) 112 (70%) 61 (71%) 51 (69%)